Ywan Karlen, general manager EMEA, Ascentium Talent looks at why compliance-first AI training is the only kind European pharma will trust in 2026 — and what that means for L&D procurement.
Shutterstock - Quality Stock Arts
Why compliance-first AI training is the only kind pharma will trust in 2026
Ywan Karlen, general manager EMEA, Ascentium Talent looks at why compliance-first AI training is the only kind European pharma will trust in 2026 — and what that means for L&D procurement.
Published:
|
4 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.